Close

Welcome back to Stockhouse
Member Sign In

Email or Username:
Password:
Close

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Enter your email address:
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Quote  |  Bullboard  |  News  |  Opinion  |  Level II  |  Charts  |  Profile  |  Financials  |  Options  |  Price History  |  Analysts  |  Earnings  |  Insiders

Avivagen Inc V.VIV

Sector: Healthcare | Sub-Sector: Drug Manufacturers - Major
Alternate Symbol(s):  CHEXF

Avivagen Inc is a development-stage company. The Company develops small-molecule compound discoveries for commercialization in markets in distinct biotechnology sectors.
Price: $0.06 | Change: $-0.005 | %Change: -7.69%
Volume: 459,000 | Day High/Low: 0.065/0.06 | 52 Week High/Low: 0.08/0.055
View modes: 
0 stars

RE:RE:RE:RE:RE:RE:More good news

Yay very cool. However, they have been excited for years dude. We need big time sales.  rate and reply
0 stars

RE:I think this is gonna happen!

Welcome back JD..it's been awhile  rate and reply
0 stars

I think this is gonna happen!

It's been a time-consuming struggle but I think that Avivagen is finally gathering some steam. I've been chatting with friends and we've pretty much all moved this up the priority list. Glad to see...read more
0 stars

RE:RE:RE:RE:RE:RE:RE:RE:More good news

I believe u r correct on both points MMN. I think u were mentioned in the release. ? The release says@The net proceeds of the proposed offering will be used to fund working capital, product...read more
0 stars

RE:RE:RE:RE:RE:RE:RE:More good news

I am actually relieved that its not 3 million. Read the news it says PP will close within 15 business days.  Its my belief that they wanted to fill the bank with some cash to finance upcoming orders....read more
0 stars

RE:RE:RE:RE:RE:RE:More good news

kill the buzz with a .06 financing of course. At least Anthony and Groome will participate.  rate and reply
5 stars

RE:RE:RE:RE:RE:More good news

I suspect more support and buying to come into Avivagen, as the 2 PRs that just came out are Company makers. I speek to Cameron every quarter and this last week he was extremly pumped as to what 2015...read more
0 stars

RE:RE:RE:RE:More good news

HALT - That's likely a ways off for VIV but I'll keep dreaming about that. At least it helps keep me sitting on my hands with this one ;)  rate and reply
0 stars

RE:RE:RE:More good news

Wounded, we only assume a monthly purchase plan of $1200 by Groome but I noted last month that that also stopped in September. The biggest supporter of VIV was Burton's son (bloom-burton) but that...read more
0 stars

RE:RE:RE:More good news

Now lets see if we get to stay or if the .06's will sell us back down again.  rate and reply
0 stars

RE:RE:More good news

Freedom...A company purchase plan is not affected by a company blackout. On the other hand I am sure he is frustrated, but he is committed. Good to finally see some buying.  rate and reply
0 stars

RE:More good news

I do own a good amount of shares but as the news flow continues to appear positive, the one glaring concern continues to be the lack of Insider Buying. I don't consider the CEO spending $1200 per...read more
0 stars

More good news

Peer-Reviewed Publication of Independent Research Provides Further Supporting Evidence for Efficacy of Natural Alternative to Antibiotic Use in Livestock   (via Thenewswire.ca) Ottawa, ON /...read more
0 stars

A good sized order

And this should start to move..until then????  rate and reply
0 stars

NR - Avivagen Announces Results from Efficacy Studies of Nat

Avivagen Announces Results from Efficacy Studies of Natural Alternative to Antibiotic Use in Swine and Poultry OTTAWA, ONTARIO / TNW-ACCESSWIRE / November 24, 2014 / Avivagen Inc. (TSXV: VIV...read more
0 stars

News: Avivagen says OxC-beta trials show commercial utility

This is a huge milestone for Avivagen: AVIVAGEN ANNOUNCES RESULTS FROM EFFICACY STUDIES OF NATURAL ALTERNATIVE TO ANTIBIOTIC USE IN SWINE AND POULTRY Avivagen Inc. has released preliminary...read more
0 stars

New report

November 24, 2014 - 7:00 AM EST   ...read more
0 stars

RE:RE:RE:RE:Health Canada

Riggght! Thanks for that!  rate and reply
5 stars

RE:RE:RE:Health Canada

You are correct, in Canada they have to run expensive trials to get approvals of HC and we all know how long those take. They idea is to capilize on markets that are larger and use third party tests...read more
0 stars

RE:RE:Health Canada

There was something contradictory about the canadian gov'ts position, but I can't remember the details. But it's why Avivagen is not for sale in Canada. Even though Viv had grants from the Canadian...read more